Concepedia

Publication | Open Access

Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States

DOIFull Paper Access

15

Citations

10

References

2014

Year

Huan Huang, Douglas C.A. Taylor, Robyn T. Carson, Phil Sarocco, Mark Friedman, Michael Munsell, Steven I. Blum, Joseph Menzin
Journal of Medical Economics

Abstract

Linaclotide was found to be a less costly option vs lubiprostone for the treatment of adult patients with IBS-C.

References

YearCitations

Page 1